Harry Alcorn, Jr.
2021
In 2021, Harry Alcorn, Jr. earned a total compensation of $545.3K as Senior Vice President of Clinical Operations at DiaMedica Therapeutics, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $73,107 |
|---|---|
| Option Awards | $154,999 |
| Salary | $302,112 |
| Other | $15,050 |
| Total | $545,268 |
Alcorn received $302.1K in salary, accounting for 55% of the total pay in 2021.
Alcorn also received $73.1K in non-equity incentive plan, $155K in option awards and $15.1K in other compensation.
Rankings
In 2021, Harry Alcorn, Jr.'s compensation ranked 10,540th out of 12,415 executives tracked by ExecPay. In other words, Alcorn earned more than 15.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,540 out of 12,415 | 15th |
Division Manufacturing | 4,662 out of 5,505 | 15th |
Major group Chemicals And Allied Products | 2,095 out of 2,375 | 12th |
Industry group Drugs | 1,859 out of 2,096 | 11th |
Industry Pharmaceutical Preparations | 1,380 out of 1,546 | 11th |
Source: SEC filing on April 5, 2022.
Alcorn's colleagues
We found two more compensation records of executives who worked with Harry Alcorn, Jr. at DiaMedica Therapeutics in 2021.